Implied Volatility Surging for Teck Resources (TECK) Stock Options
Rigel Pharmaceuticals, Inc. RIGL was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.68–$3.43 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Rigel Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00.
Rigel Pharmaceuticals, Inc. Price
Rigel Pharmaceuticals, Inc. Price | Rigel Pharmaceuticals, Inc. Quote
A better-ranked stock in the Medical – Drugs industry is BioSpecifics Technologies Corp. BSTC, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is RIGL going up? Or down? Predict to see what others think:Up or Down
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Click to see them right now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BioSpecifics Technologies Corp (BSTC) : Free Stock Analysis Report
Rigel Pharmaceuticals, Inc. (RIGL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research